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NF-Y is a heterotrimeric transcription factor that spe-
cifically recognizes a CCAAT box motif found in a vari-
ety of eukaryotic promoter and enhancer elements. The
subunit association and DNA binding properties of the
NF-Y complex were examined as a function of redox
state using recombinant NF-YA, NF-YB, and NF-YC sub-
units. Reduction of NF-YB by dithiothreitol (DTT) was
essential for reconstitution of specific NF-Y CCAAT box
DNA binding activity in vitro. Approximately 30% of the
Escherichia coli-derived NF-YB subunit existed as inter-
molecular disulfide-linked dimers. NF-YB mutants in
which the highly conserved cysteine residues at posi-
tions 85 and 89 had been converted to serines existed
only as monomers and did not require DTT for func-
tional NF-Y DNA binding activity. DTT was required,
however, for the functional association of NF-YC with
wild-type NF-YB but not with the NF-YB cysteine mu-
tants. The cellular redox factors Ref-1 and adult T-cell
leukemia-derived factor stimulated the DNA binding ac-
tivity of recombinant NF-Y in the absence of DTT. Cells
treated with 1-chloro-2,4-dinitrobenzene, an irreversi-
ble inhibitor of thioredoxin reductase, exhibited re-
duced endogenous NF-Y DNA binding activity. Together
these results suggest that the cellular redox environ-
ment of mammalian cells is an important posttranscrip-
tional regulator of NF-Y subunit association and DNA
binding activities.
NF-Y is a ubiquitous multimeric eukaryotic transcription
factor, also referred to as CP1 (1) and CBF (2), that recognizes
a CCAAT motif often found ;60–80 base pairs upstream of the
RNA polymerase II initiation site in the promoter region and at
various locations in distant enhancer elements of many higher
eukaryotic genes. Cloning of the murine NF-Y subunits NF-YA
and NF-YB revealed a high degree of conservation with the
subunit association and DNA binding domains of two yeast
CCAAT box transcription factors, HAP2 and HAP3, respec-
tively (3). Early analyses of the CP1, HAP, and NF-Y complexes
suggested that only these two subunits were required for
CCAAT box recognition (1, 3, 4). However, recent cloning of an
additional yeast subunit, HAP5 (5) and the rat CBF subunit
CBF-C (6) and reconstitution studies of specific CCAAT box
DNA binding activity in these systems now support the conclu-
sion that the DNA binding activity of the HAP and CBF(NF-Y)
complexes resides in the specific association of three noniden-
tical subunits (5–7).
The CCAAT box DNA binding activities of the CP1, HAP,
and CBF complexes was shown initially to separate into two
distinct fractions following ion exchange chromatography in
which the lost DNA binding activity could be fully reconsti-
tuted by fraction recombination (1, 2, 8). These combined stud-
ies suggested that the interaction of the HAP2 and CBF-B(NF-
YA) subunits with other components of the complex was
primarily ionic in nature, and further suggest that under ap-
propriate conditions the HAP2 and CBF-B subunits can ex-
change their heterodimeric partners. Subsequent biochemical
analysis of the CBF-A(NF-YB) fraction suggested that CBF-A
was tightly associated with an additional component, CBF-C,
and that this interaction was primarily hydrophobic in nature,
since these subunits could only be separated after treatment
with denaturants such as urea, guanidine hydrochloride, and
sodium dodecyl sulfate (7). The CBF-B(NF-YA) subunit has
also been shown to interact with the CBF-AzCBF-C complex but
not with CBF-A(NF-YB) or the CBF-C subunit individually (6),
suggesting that a unique association surface for CBF-B(NF-
YA) is created by the CBF-AzCBF-C heterodimer.
Structural and functional analyses have shown that the
CBF-B(NF-YA) subunit contains an 83-amino acid long evolu-
tionarily conserved domain, which contains determinants of
the subunit association (amino acids 266–286) and DNA bind-
ing (amino acids 297–317) activities (9, 10). Mutation of hydro-
phobic amino acids within the subunit association domain of
CBF-B(NF-YA) results in loss of function (9, 10). The amino
acids N-terminal to the subunit association domain are rich in
glutamine residues and function as a trans-activation domain
(11, 12). There are at least two major isoforms of NF-YA(CBF-
B), which differ primarily at the N terminus due to tissue-
specific alternative splicing but which exhibit no apparent
functional difference in cell-free in vitro transcription assays
(11). The DNA binding and subunit association domains of
CBF-A(NF-YB) have also been mapped recently (13). Amino
acid regions 57–87, 92–99, and 63–102 along with amino acids
109–142 of CBF-A(NF-YB) are required for DNA binding,
CBF-B(NF-YA) association, and CBF-C association, respec-
tively. Several of the evolutionarily conserved amino acids
within the DNA binding and subunit association domains have
also been shown to be important for the function of CBF-A(NF-
YB) (13), as has a similar analysis of HAP3 demonstrated the
importance of these evolutionary conserved amino acids (14).
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Surprisingly, the evolutionarily conserved cysteine residues,
which were previously proposed to be critical for DNA binding
(3), were found to be dispensable for CBF(NF-Y) complex DNA
binding activity (14).
Cysteine residues of several transcription factors, although
not directly involved in DNA binding, modulate DNA binding
activity in response to the cellular redox state. In the case of the
oxyR protein, oxidation of cysteines induces DNA binding ac-
tivity (15), whereas, in the case of transcription factors Fos,
Jun, bovine papillomavirus E2, NF-kB, c-Myb, USF, and
TTF-1, in vitro DNA binding activity in all these cases is
stimulated by reduction of specific cysteine residues (16–21).
With a long-term goal of identifying posttranslational modifi-
cation events that influence the DNA binding and transcrip-
tional activation potential of NF-Y(CBF), the biochemical na-
ture of its subunit interactions and to understand the role that
the highly conserved cysteine residues of NF-YB(CBF-A) play
in overall NF-Y function, we have initiated studies of the NF-Y
complex using recombinant NF-Y subunits. For this purpose,
we isolated cDNAs corresponding to both the human and mu-
rine NF-YC subunit, and we show in this study that human
andmurine NF-YC contain an evolutionarily conserved domain
of 81 amino acids, which displays 74% homology to yeast HAP5.
DNA binding studies using all three recombinant subunits
indicated that reduction of recombinant NF-YB by reducing
agents such as dithiothreitol (DTT)1 or mammalian enzymes
involved in redox regulation such as Ref-1 and thioredoxin
(21–23) are essential for NF-Y DNA binding activity. In addi-
tion, we show that NF-YB with mutation of cysteine residues at
positions 85 and 89 can bind DNA and does not require DTT.
Subunit association studies indicated that prior reduction of
wild-type NF-YB is essential for its association with NF-YC.
We also demonstrate that cysteine-modifying agents inhibit
DNA binding of cellular NF-Y. The implications of these
findings on expression of NF-Y(CBF)-regulated genes are
discussed.
MATERIALS AND METHODS
Cloning of Human and Mouse NF-YC—The human NF-YC subunit
was cloned from a HeLa cell cDNA library (Clontech), and the murine
NF-YC subunit was cloned from a normal murine macrophage cDNA
library (Clontech) by polymerase chain reaction (PCR) using primers
59-GGGGATCCATGTCCACAGAAGGAGGG-39 and 59-GGGAATTCT-
CAGTCTCCAGTCACCTGGGG-39 based on the rat CBF-C cDNA se-
quence (6). PCR products derived from several independent reactions
were cloned into the pGEX-2T vector (Pharmacia Biotech Inc.) to gen-
erate NF-YC subclones, and for each species clones were sequenced on
both strands by Dye-Deoxy Terminator cycle sequencing (Applied Bio-
systems Division, Perkin-Elmer) using an automated Applied Biosys-
tems DNA sequencer.
Construction of Recombinant Plasmids—cDNAs for NF-YA and
NF-YB were obtained from a murine 3T3-L1 fibroblast cDNA library
(Clontech) by PCR with primer sequences derived from previously pub-
lished full-length murine sequence data (3). cDNAs were cloned into the
BamHI-EcoRI sites of the pGEX-2T vector (Pharmacia) to generate the
glutathione S-transferase (GST) fusion proteins GST-YA and GST-YB.
Cysteine mutations in NF-YB were created by a two-step PCR ampli-
fication technique as described by Ho et al. (24) using GST-YB as a
template and cloned into pGEX-2T. NF-YC, NF-YB, and cysteine mu-
tants of NF-YB were also cloned into the XhoI-BamHI sites of the
pET15b vector (Novagen) to generate histidine-tagged NF-Y subunits.
A prokaryotic expression vector containing a human acute T-cell leu-
kemia-derived factor (ADF) cDNA was provided by Dr. K. Schulze-
Osthoff (German Cancer Research Center, Heidelberg, Germany;
Ref. 25).
Purification of Recombinant Proteins—GST-YA and GST-YC pro-
teins were purified from the soluble fraction of Escherichia coli DH5a
lysates essentially as described by Smith and Johnson (26). GST-YB
was prepared from inclusion bodies as described by Sambrook et al. (27)
and then solubilized and diluted to a protein concentration of 1 mg/ml
in a buffer containing 20 mM HEPES, pH 7.9, 0.5 mM EDTA, 300 mM
KCl, and 8 M urea. Polyethylene glycol 8000 was added in a ratio of 1:15
(w/w) (28), and the urea concentration was decreased to 4 M by addition
of an equal volume of buffer containing 20 mM HEPES, pH 7.9, 0.5 mM
EDTA, and 300 mM KCl. The denatured proteins were then refolded by
sequential dialysis in 3 M, 2 M, and 1 M urea-containing buffers and a
final buffer without urea at 1-h intervals. Renatured GST-YB was
purified from using glutathione-agarose beads (Sigma) (26).
YB and YC proteins expressed in E. coli strain BL21(DE3) from pET
vectors were purified from inclusion bodies under denaturing condi-
tions. Briefly, isolated inclusion bodies were dissolved in binding buffer
(20 mM HEPES, pH 7.9, 300 mM KCl, 20% glycerol, and 6 M guanidine-
HCl) and applied to a His-Bind agarose column (Novagen) pre-equili-
brated with binding buffer. The column was washed extensively in
binding buffer containing 10 mM imidazole. The column-bound NF-Y
proteins were eluted using a 100 mM–1 M step gradient of imidazole in
binding buffer. The purity of all E. coli-derived proteins was assessed by
Coomassie Blue staining of SDS-PAGE gels and was 90% or greater.
Fractions containing high DNA binding activity as measured by elec-
trophoretic mobility shift assays (EMSAs) were used in subsequent
analyses. All recombinant proteins were dialyzed against buffer D (20
mM HEPES, pH 7.9, 100 mM KCl, 20% glycerol, 0.5 mM EDTA, and 0.5
mM phenylmethylsulfonyl fluoride) and stored at 280 °C. Recombinant
ADF was purified as described previously (25). HSP90 was purchased
from StressGen Biotechnologies (Sidney, Canada); Ref-1 and cyclophi-
lin were provided by Drs. Tom Curran (St. Jude Children’s Hospital,
Memphis, TN) and Barbara Sherry (The Picower Institute, Manhasset,
NY), respectively. Cell culture supernatants from the MT4 cell line
were concentrated using Centricon-3 ultrafiltration devices (Amicon),
and the concentrated mediumwas extensively dialyzed against buffer D
to remove any reducing agents.
NF-YB Antibodies and Western Blotting—Purified GST-YB fusion
protein as described above was used for rabbit immunizations. Anti-YB
antibodies were affinity-purified from rabbit serum using a GST-YB-
Sepharose affinity column as described previously (29). Affinity-puri-
fied antibodies were passed through an additional GST-Sepharose col-
umn to remove antibodies directed against GST. Western blotting of
proteins transferred from polyacrylamide gels to nitrocellulose filters
was performed using a 1:1000 dilution of primary antibody, and anti-
gen-antibody complexes were detected using ECL (Amersham).
Whole Cell Extracts and EMSAs—Whole cell extracts derived from
exponentially growing HeLa cells were prepared by subjecting cells
suspended in whole cell extraction buffer (20 mM HEPES, pH 7.9, 400
mM NaCl, 20% glycerol, 0.5 mM phenylmethylsulfonyl fluoride, and 2
mg/ml aprotinin, pepstatin A, and leupeptin) to three cycles of freeze-
thawing in liquid nitrogen and ice. EMSAs were performed with either
15 mg of whole cell extract protein or ;10 ng of each recombinant
subunit in DNA binding buffer (10 mM Tris, pH 7.9, 1 mM EDTA, 2 mg
poly(dI-dC)zpoly(dI-dC), 100 mM KCl, and 10% glycerol) with or without
0.5 mM DTT. Extracts were first incubated on ice with poly(dI-dC) for 10
min before addition of a 32P-labeled probe and then electrophoresed on
5% polyacrylamide/0.5 3 Tris/borate/EDTA gels as described previously
(30). The murine MHC class II Ea Y-box oligomer duplex (59-
GGCATTTTTCTGATTGGTTAAAAGTTG-39 and 59-GGCTCAACTTT-
TAACCAATCAGAAAAAT-39) was end-labeled using the large subunit
of DNA polymerase I and [a-32P]dCTP as described previously (30).
NF-kB and AP-1 binding site-containing oligomers were purchased
from Promega (Madison, WI). SRF binding site oligomer and a-SRF
antibodies were obtained from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA). Antibody upshift experiments and oligomer labeling with
[g-32P]ATP and T4 polynucleotide kinase were performed according to
the manufacturer.
In Vitro Protein-Protein Interaction Assay—Approximately 50 ng of
recombinant NF-YB and individual cysteine mutants were incubated
with ;50 ng of recombinant GST-YC for 30 min at 37 °C in binding
buffer (10 mM Tris, pH 7.9, 1 mM EDTA, 100 mM KCl, 10% glycerol, and
0.5 mM phenylmethylsulfonyl fluoride) under nonreducing and reducing
conditions (1.0 mM DTT). Glutathione-agarose (10-ml bead volume) pre-
equilibrated in binding buffer was added, and the reaction binding
buffer volume was increased to 200 ml. Incubation continued at room
1 The abbreviations used are: DTT, dithiothreitol; ADF, adult T-cell
leukemia-derived factor; BSO, buthionine sulfoximine; CDNB, 1-chloro
2,4-dinitrobenzene; EMSA, electrophoretic mobility shift assay; GST,
glutathione S-transferase; NEM, N-ethylmaleimide; PCR, polymerase
chain reaction; SRE, serum response element; SRF, serum response
factor; PAGE, polyacrylamide gel electrophoresis; MHC, major his-
tocompatibility complex; CYP1A1, cytochrome P450-dependent
monooxygenase.
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temperature for 1 h with gentle mixing. Glutathione-agarose beads
were pelleted, washed five times in binding buffer containing 0.5%
Triton X-100 at 4 °C, and resuspended in SDS-PAGE buffer containing
50 mM DTT. Samples were separated on a 10% acrylamide SDS-PAGE
gel, transferred to nitrocellulose, and analyzed by Western blotting.
RESULTS
Human and Mouse NF-YC and Their Homology to Rat
CBF-C and Yeast HAP5—Previous studies have indicated that
the amino acid sequences of NF-YA and NF-YB are conserved
in evolution, particularly in their DNA binding and subunit
association domains (31). To determine whether NF-YC is also
similarly conserved, we cloned the human and mouse NF-YC
subunits by PCR and compared their sequences. The deduced
amino acid sequences from these cDNAs and their homology to
rat CBF-C and yeast HAP5 are shown in Fig. 1. Similar to
human NF-YA and NF-YB, which are more than 99% homolo-
gous to the corresponding mouse subunits (31), human NF-YC
was observed to be 96.5% homologous to mouse NF-YC (Fig.
1A). Amino acids at positions 43–124 of human, mouse, and rat
NF-YC displayed 70% sequence homology to amino acids 134–
215 of HAP5 in a manner analogous to the NF-YA and NF-YB
subunits, which contain domains homologous to yeast HAP2
and HAP3, respectively (Fig. 1B). This region of NF-YC pre-
sumably contains the determinants of additional NF-Y subunit
association and DNA binding activities. The secondary protein
structure analysis of Chou and Fasman (32) indicated that the
HAP5 homology region of NF-YC, like similar domains of
NF-YA and NF-YB, can form an a-helical structure (data not
shown). The HAP2 homology domain of NF-YA and the HAP5
homology domain of NF-YC may also be organized in a similar
manner in that they contain highly homologous N- and C-
terminal subdomains separated by a variable linker region (31,
33). For example, amino acids 43–85 and 111–124 of NF-YC
are 79 and 72% homologous to amino acids 134–176 and 202–
215 of HAP5, respectively, whereas the intervening amino ac-
ids 86–110 are only 52% homologous to amino acids 177–201 of
HAP5 (Fig. 1B). Amino acids C-terminal to the HAP 5 homol-
ogy domain contain 30% glutamine residues (Fig. 1A) in which
two subdomains (amino acids 150–165 and 199–216) contain
more than 50% glutamine residues. Thus, glutamine-rich re-
gions of NF-YC and NF-YA are organized in a similar fashion
and may each represent specific trans-activation domains (3,
11). Taken together, sequence data homology comparisons in-
dicate that NF-YA and NF-YCmay contain structurally similar
DNA binding, subunit association, and trans-activation
domains.
DNA Binding of Recombinant NF-Y Proteins Prepared under
Nonreducing Conditions—The cysteine residues of HAP3, al-
though conserved evolutionarily, were previously shown not to
be essential for DNA binding activity (14). To investigate
whether the cysteine residues of NF-YB are essential for DNA
binding and whether these same cysteine residues regulate
DNA binding activity in response to redox environment, EM-
SAs using recombinant subunits were performed (Fig. 2). NF-Y
subunits were mixed and preincubated for 15 min at 25 or
37 °C. Under nonreducing conditions a low level of NF-Y com-
plex formed with a MHC class II Ea CCAAT box oligonucleo-
tide probe (Fig. 2, lanes 1 and 3). However, inclusion of DTT in
the preincubation step enhanced the DNA binding activity of
recombinant NF-Y subunits by ;15-fold (Fig. 2, lanes 2 and 4).
This property of recombinant NF-Y is similar to the property of
recombinant Fos and Jun proteins, which also require treat-
ment with a reducing agent to observe efficient DNA binding
activity (16). To identify the specific cysteine residues of NF-YB
that were responsible for redox-dependent DNA binding, we
tested the DNA binding activity of NF-YB in which cysteine
residues had been mutated to serine. The YBC3 mutant, in
which cysteine residue at amino acid position 105 has been
mutated to serine, specifically bound DNA only in the presence
of DTT (Fig. 2, lanes 5–8). YBC12, in which cysteines at posi-
FIG. 1. Evolutionary conservation of the NF-YC subunit. A,
alignment of the human (H) and mouse (M) NF-YC with the rat (R)
CBF-C (3) amino acid sequences. Dots, identical amino acids in all three
species. B, comparison of an N-terminal region of human and mouse
NF-YC with the C terminus of yeast HAP5 (5).
FIG. 2. DNA binding of recombinant NF-Y complexes to the
MHC class II Ea Y-box probe. Radiolabeled Ea probe was incubated
with the indicated combination of NF-Y subunits and subjected to
EMSA analysis. Subunits were incubated with (1) or without (2) 1 mM
DTT at the indicated temperature (TEMP, in °C) for 15 min before the
addition of the 32P-Ea probe. Recombinant NF-YA is GST-YA, whereas
NF-YB and NF-YC are histidine-tagged fusion proteins.
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tion 85 and 89 had been mutated, and YBC123, in which all
three cysteines were mutated, were able to form a NF-YzDNA
complex in the absence of DTT (Fig. 2, lanes 9–16). These
results suggest that cysteines 85 and 89 of NF-YB must be
reduced for NF-Y to efficiently bind CCAAT box DNA. In ad-
dition, these results indicate that, similar to yeast HAP3, the
cysteine residues of NF-YB are not required for DNA binding
activity (14). NF-Y subunits cleaved with thrombin to remove
either GST or the polyhistidine residues from the NF-Y sub-
units behaved similarly to the fusion proteins described above
(data not shown).
NF-YB Can Form a Covalently Linked Dimer—Since the
DNA binding activity of wild-type NF-YB was affected by redox
perturbations, we examined whether this effect was due to an
internal disulfide bridge and/or due to intermolecular disulfide
bridges formed under nonreducing conditions. To this end,
NF-YB and its cysteine mutants were analyzed on a SDS-
PAGE gel under nonreducing and reducing conditions (Fig. 3).
Approximately 70% of both wild-type YB and YBC3 were ob-
served to migrate as monomers, whereas the remaining 30%
migrated as an apparent dimeric species (;68 kDa) when re-
solved under nonreducing conditions (Fig. 3, lanes 1 and 3).
DTT treatment converted the dimers to monomers (Fig. 3,
lanes 2 and 4). However, only the monomeric forms of YBC12
and YBC123 were detected in this analysis (Fig. 3, lanes 5–8).
These results also suggest that either cysteine 85 or 89 is
involved in dimer formation. Although the above analysis can-
not prove that intramolecular disulfide bonds in YB exist under
nonreducing conditions, we believe that the majority of mono-
meric YB molecules contain intramolecular disulfide bonds,
since the reduction of dimers to monomers alone cannot ac-
count for the magnitude of the DTT effect on overall NF-Y DNA
binding activity (Fig. 2).
Recombinant NF-YB Fails to Associate with NF-YC Under
Nonreducing Conditions—Although the DNA binding studies
and SDS-PAGE analysis indicated that NF-YB is the target of
DTT, the above analysis was not sufficient to determine
whether the failure of nonreduced NF-YB to bind DNA was due
to its inability to interact with NF-YC or a defect in contacting
DNA. To address this issue, we studied the association of
NF-YB and NF-YC in the absence of DNA. As shown in Fig. 4,
only low levels of the wild-type NF-YB and YBC3 mutant
subunits were retained on a glutathione S-transferase-NF-YC
(GST-YC) column under nonreducing condition (lanes 1 and 3).
However, under reducing conditions, there was a dramatic
increase in the amount of both YB and YBC3 retained by the
GST-YC column (Fig. 4, lanes 2 and 4). The YBC12 and
YBC123 mutants were retained by the GST-YC column under
both nonreducing and reducing conditions (Fig. 4, lanes 5–8).
For unknown reasons, DTT treatment enhanced the associa-
tion of YBC12 with GST-YC, although the DNA binding activ-
ity of this mutant was not influenced by DTT (Fig. 2). These
results suggest that NF-YB modified with either intermolecu-
lar and intramolecular disulfide cross-links fails to interact
with NF-YC, and this failure is responsible for the significant
reduction in DNA binding activity.
An Activity in Cell Lysates Facilitates DNA Binding of Re-
combinant NF-Y—To explore whether there is a cellular com-
ponent that can functionally replace DTT reduction of cysteine
residues, we incubated recombinant NF-Y subunits with HeLa
cell extract that had been heat-treated to inactivate endoge-
nous NF-Y (34). No NF-Y binding activity was detected in
heat-treated HeLa cell extracts (Fig. 5A, lanes 3 and 4), and the
DNA binding activity could be restored by addition of recombi-
nant NF-YC (Fig. 5A, lanes 9 and 10). These results suggest
that NF-YC is the heat-sensitive subunit in the NF-Y complex.
Addition of GST-YB and recombinant YC to heat-treated ex-
tracts gave rise to a NF-Y complex composed of cellular NF-YA,
GST-YB, and recombinant NF-YC (Fig. 5A, lanes 13 and 14).
This complex was generated in the absence of DTT treatment,
suggesting that a cellular factor could convert oxidized GST-YB
to its reduced form.
Analysis of the redox-regulated transcription factors Fos and
Jun has indicated that a cellular factor, Ref-1, can stimulate
DNA binding activity of these factors by acting as a reducing
agent (22, 23). Similarly, ADF has been shown to stimulate
NF-kB DNA binding by acting as a reducing agent (19). To
determine whether any of these factors can functionally replace
DTT in stimulating the DNA binding activity of recombinant
NF-Y, DNA binding assays were performed in the presence of
Ref-1, ADF, and cell culture supernatant derived from the
human T-lymphotropic virus 1-transformed cell line MT4,
which contains ADF. Assays were also performed in the pres-
ence of E. coli thioredoxin, cyclophilin, and HSP90. Among
these reagents, Ref-1, ADF, and the MT4 cell culture superna-
tant stimulated DNA binding activity of recombinant NF-Y in
the absence of DTT (Fig. 5B, lanes 5, 7, and 9). These results
raise the possibility that the DNA binding activity of cellular
FIG. 3.NF-YB forms covalently linked dimers under nonreduc-
ing conditions. Recombinant wild-type NF-YB and its cysteine mu-
tants were dissolved in SDS-PAGE buffer with (1) or without (2) 50 mM
DTT and compared on 10% polyacrylamide SDS-PAGE. Recombinant
proteins were detected by Western blotting and ECL using affinity-
purified a-NF-YB polyclonal antibodies. The masses of protein stand-
ards in kDa are denoted at the right.
FIG. 4. Association of wild-type and cysteine mutant NF-YB
subunits with NF-YC. Indicated histidine-tagged NF-YB subunits
were incubated with GST-YC fusion proteins with (1) or without (2) 1
mM DTT and bound to glutathione-agarose beads. GST-YC-associated
NF-YB was analyzed by Western blotting. Incubations in all even num-
bered lanes contained 1 mM DTT.
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NF-Y is also regulated by cellular redox systems.
NF-Y DNA Binding Activity Is Reduced in Cells Depleted of
Thioredoxin—A possible role of cellular thioredoxin in the reg-
ulation of cellular NF-Y was investigated using several chem-
ical agents by testing the effect of buthionine sulfoximine
(BSO), which specifically inhibits g-glutamyl cysteinyl synthe-
tase, an enzyme essential in glutathione synthesis (35), and
1-chloro 2,4-dinitrobenzene (CDNB), an irreversible inhibitor
of human thioredoxin reductase (36). NF-Y DNA binding activ-
ity in HeLa cells treated with either BSO or CDNB is shown in
Fig. 6. Cells treated with CDNB, but not BSO, displayed 50%
less NF-Y DNA binding activity compared with untreated cells
(lanes 1–6). Surprisingly, the lost NF-Y DNA binding activity
could not be recovered by DTT treatment (Fig. 6, compare lanes
5 and 6). Although the reason for this behavior is not known,
one possibility is that oxidized NF-YB is unstable in these
chemically treated cells and is targeted for proteolysis. How-
ever, Western blot analysis of these treated HeLa cell extracts
showed that neither YB subunit isoform (37) was proteolyzed
(Fig. 6, compare lanes 19–21). In contrast to NF-Y, the CDNB
effect on AP-1 and NF-kB could be partially reversed by DTT
treatment (Fig. 6, compare lane 11 with lane 12 and lane 17
with lane 18). These results suggest that a number of transcrip-
tion factors including NF-Y require a functional thioredoxin-
thioredoxin reductase-mediated redox system to maintain
functional DNA binding activity.
NF-Y DNA Binding Activity Is Inactivated by N-Ethylmale-
imide—To further investigate the role of sulfhydryl groups in
NF-Y DNA binding, we testedN-ethylmaleimide (NEM), which
alkylates free sulfhydryl groups, and diamide, which catalyzes
the oxidation of free sulfhydryl groups (38). NF-Y DNA binding
activity was completely abolished after incubation of cell ex-
tracts with 1 mM NEM (Fig. 7, lane 2). Addition of 20 mM DTT
prior to incubation with NEM prevented inactivation of NF-Y
(Fig. 7, lane 3). NF-Y bound to its CCAAT box site was partially
protected from NEM inactivation, indicating that these reac-
tive sulfydryl groups are in close proximity to DNA (Fig. 7, lane
4). Treatment with diamide at 5 and 10 mM resulted in a slight
decrease in NF-Y DNA binding activity (Fig. 7, lanes 5 and 6).
To determine whether diamide treatment creates disulfide
cross-linked dimers or an unstable sulfenyl hydrazene inter-
mediate (40), we first treated nuclear extracts with diamide
and then with NEM. No NF-Y DNA binding activity was ob-
served on diamide and NEM co-treatment (Fig. 7, lane 7).
However, on addition of DTT to diamide- and NEM-co-treated
nuclear extracts, substantial NF-Y DNA binding activity could
be recovered (Fig. 7, lane 8). These results suggest that NF-YB
formed a disulfide cross-linked dimer either to itself or to other
proteins, and this oxidation prevented NEM from alkylating
cysteine residues. Note that the serum response element (SRE)
DNA binding activity of the extract was not abolished by either
NEM or diamide treatment, suggesting that the effect of NEM
and diamide is specific to NF-Y.
DISCUSSION
In this report, we have investigated the role of the highly
conserved NF-YB cysteine residues on the overall DNA binding
and subunit association activities of the multimeric NF-Y com-
plex. Our results suggest that the cysteine residues of NF-YB
do not play an obligatory role in the DNA binding activity of
NF-Y but do play an important regulatory role in the redox
regulation of NF-Y DNA binding activity through protein-pro-
tein interaction with the NF-YC subunit.
Oxidized NF-YB Fails to Associate with NF-YC—Recent mu-
tational analysis of the CBF-A(NF-YB) subunit has indicated
that amino acids 63–102 and 109–142 are required for its
association with CBF-C, whereas amino acids 57–87 are re-
quired for DNA binding activity (13). In addition, mutation of
amino acid 87 in CBF-A(NF-YB) prevents the CBF complex
from binding CCAAT box DNA without affecting its association
FIG. 5. Cellular factors can functionally substitute for DTT in
activating NF-Y DNA binding activity. A, HeLa cell factor enables
GST-YB to bind the Ea probe in the absence of DTT. EMSA reactions
were performed with the Ea probe and heat-inactivated HeLa cell
extract either alone (lanes 3 and 4), or with GST-YA (lanes 5 and 6),
GST-YB (lanes 7 and 8), His-tagged YC (lanes 9 and 10), GST-YA plus
His-tagged YC (lanes 11 and 12), and GST-YB plus His-tagged YC
(lanes 13 and 14). DTT was included in lanes 4, 6, 8, 10, 12, and 14. B,
GST-YA, His-tagged YB, and His-tagged YC (approximately 10 ng)
were incubated alone (lanes 1 and 2) or with 10 ng of E. coli thioredoxin
(lanes 3 and 4), recombinant ADF (lanes 5 and 6), Ref-1 (lanes 7 and 8),
MT4 cell culture supernatant (lanes 9 and 10), cyclophilin (lanes 11 and
12), or HSP90 (lanes 13 and 14) and subjected to EMSA using the Ea
probe. Incubations in all even-numbered lanes contained 1 mM DTT.
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with CBF-C, whereas mutation of amino acid 86 prevents
CBF-A from associating with CBF-C and CBF-B(NF-YA) (13).
Since NF-YB(CBF-A) cysteine residues 85 and 89 are located in
a region shown to be important for interaction with NF-YC and
are redox-sensitive (Fig. 2), an intramolecular disulfide cross-
link between cysteines 85 and 89 may alter the conformation
and overall recognition surface of NF-YB in this region and
explain why functional interaction with NF-YC is prevented
(Fig. 4).
As first noted by Baxevanis et al. (39) and Sinha et al. (13),
amino acids 59–140 of NF-YB(CBF-A) exhibit a weak struc-
tural homology to a region in histone H2B, the histone fold
motif, which comprises a short a-helix (;10 residues) followed
by a loop and b-strand segment, a long a-helix (;27 residues),
a second loop and b-strand segment, and another short a-helix
(10 residues) and is involved in protein-protein interactions
with histone H2A in the histone octamer complex (40). The
protein secondary structure predictions of Chou and Fasman
(32) indicate that amino acids 70–140 of NF-YB(CBF-A) fold
into an alternating array of five a-helices and b-sheets (data
not shown). Amino acids in the second and third helices of
NF-YB show weak homology to amino acids of histone H2B
that form the long 27-residue a-helix. Cysteines 85 and 89 are
located in the second a-helix region, and helical wheel projec-
tion in this region indicates that both of these cysteines are
located on the same side of the a-helix. This side of the helix is
also surrounded by hydrophobic amino acids. Consistent with
these observations, a number of biochemical experiments have
indicated that cellular NF-YB and NF-YC associate through
their hydrophobic surfaces, as their protein-protein interac-
tions can be disrupted by denaturants such as urea and gua-
nidine-HCl (7; data not shown). How the proposed structural
features described above will be affected by oxidation of cys-
teines 85 and 89 remains to be investigated.
Identification of intermolecular disulfide cross-linked dimers
of NF-YB (Fig. 3) raises the possibility that NF-YB itself may
possess a distinct DNA binding specificity similar to the E2A
helix-loop-helix proteins (41). E2A homodimers have been
shown to possess intermolecular disulfide cross-links, which
exist in B cells but not in muscle cells, and bind DNA recogni-
tion sites at physiological temperatures. Monomeric E2A does
not bind DNA on its own but is capable of binding DNA spe-
cifically after heterodimerizing with myoD (41). The highly
conserved region in HAP3 and NF-YB is also similar to a region
in the general transcriptional repressor Dr1 (42), and NF-YB
could possibly associate with additional Dr1 partners or other
cellular proteins that are related to the potential histone fold
motifs of NF-YA and NF-YC. Further studies are required to
test whether NF-YB also exists as cell type-specific ho-
modimers and associates with additional multimeric partners
and cofactors and if so, to determine their individual DNA
binding specificities and particular functional activities.
Biological Significance of NF-YB Redox Regulation—Regu-
lation of gene transcription by redox has been described in a
number of systems (15, 16, 43). Oxidative as well as antioxida-
tive conditions have been shown to alter the DNA binding
activity of transcription factors. For example, in bacteria, the
oxyR gene product activates a number of genes in response to
oxidative stress by binding DNA only when it is in an oxidized
state (15). Conversely, the human glucocorticoid and proges-
terone receptors bind only in the reduced form (44, 45). Simi-
larly, reduction of a cysteine residue in the DNA binding do-
mains of c-Jun and c-Fos enhances their DNA binding activity
FIG. 6. DNA binding activity of
NF-Y, NF-kB, and AP-1 derived from
HeLa cells treated with BSO or
CDNB.Whole cell extracts prepared from
HeLa cells (lanes 1, 2, 7, 8, 13, and 14),
HeLa cells treated for 24 h with 100 mM
BSO (lanes 3, 4, 9, 10, 15, and 16), and
HeLa cells treated for 15 min with 40 mM
CDNB (lanes 5, 6, 11, 12, 17, and 18) were
subjected to EMSA using the Ea probe.
Reactions in lanes 2, 4, 6, 8, 10, 12, 14, 16,
and 18 contained 1 mM DTT. HeLa ex-
tracts from control (lane 19), BSO-treated
(lane 20), and CDNB-treated (lane 21)
cells were assayed for NF-YB subunit lev-
els using a-YB antibodies and ECL.
FIG. 7. Effect of sulfhydryl modifying agents on the DNA bind-
ing activity of HeLa cell NF-Y and SRF.Whole cell extracts of HeLa
cells (lanes 1, 9, and 18) and HeLa cell extracts treated for 15 min with
1 mM N-ethylmaleimide followed by 20 mM DTT (lanes 2 and 10), 5 mM
diamide (lanes 5 and 13), 10 mM diamide (lanes 6 and 14), 10 mM
diamide followed by 1 mM NEM (lanes 7 and 15), and 10 mM diamide
followed by 1 mM NEM and 20 mM DTT (lanes 8 and 16) were subjected
to EMSAs using the Ea (lanes 1–8) and SRE (lanes 9–20) probes. To
reactions in lanes 3 and 11, 20 mM DTT was added prior to NEM
addition. In lanes 4 and 12, 1 mM NEM was added 10 min after addition
of probe. Lane 17, free 32P-SRE probe; lane 19, a-SRF antibody; lane 20,
a-NF-YB antibody. Horizontal lines, NF-YzEa and SRFzSRE complexes;
p, SRFzSRE upshifted complex.
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(16). Interestingly, in the case of c-Jun and c-Fos, this cysteine
can be mutated to serine without affecting its DNA binding
activity, and the mutant proteins bind DNA even after treat-
ment with cysteine-modifying agents. Moreover, v-Jun, the
viral counterpart of c-Jun with a mutation of its cysteine resi-
due, shows a distinct biological activity profile, possibly due to
its deregulation from redox control (16, 22). There are number
of similarities between c-Jun and NF-YB with respect to their
evolutionarily conserved cysteine residues: 1) in both cases, the
cysteine residues are embedded in a domain that is critical for
their DNA binding activity; 2) mutations of these cysteines to
serine in both cases are not deleterious to DNA binding; 3)
compounds that induce disulfide bond formation (e.g. diamide)
or alkylate cysteines (e.g. NEM) inhibit DNA binding (Fig. 7;
Ref. 16); and 4) Ref-1 can reduce the cysteine residues of both
proteins (Fig. 5B; Refs. 22 and 23). Thus, some of the cellular
factors that regulate the activity of Fos and Jun may also
regulate NF-Y function.
ADF, a human thioredoxin, was shown to increase the DNA
binding activity of recombinant NF-Y to its CCAAT box (Fig.
5B). ADF is overproduced in human T-cell lymphotropic virus
I- and Epstein-Barr virus-transformed lymphocytes and mito-
gen-stimulated peripheral blood lymphocytes (24, 46). ADF has
been hypothesized to influence cellular metabolism through
the thiol-redox control of regulatory factors. One of the primary
targets of ADF in these cells could be NF-Y, since this tran-
scription factor is essential for transcription of S/G2-specific
genes, such as cyclin A, cdc25C, cdc2, and thymidine kinase
(47, 48). ADF has also been shown to synergize with interleu-
kin-2 in induction of the tumor necrosis factor a gene in B cells
(49), and this effect of ADF could be mediated through the
functional NF-Y binding site present in the tumor necrosis
factor promoter (50). An NF-Y-related protein has been shown
to function as a repressor of cytochrome P450-dependent mo-
nooxygenase (CYP1A1) gene expression (51). The CYP1A1 gene
is induced on exposure to a variety of xenobiotics, including
halogenated hydrocarbons (e.g. dioxin) and polyaromatic hy-
drocarbons. It has been suggested that induction of functional
CYP1A1 stimulates a pathway that generates thiol-sensitive
oxygen intermediates (52). Thiol-sensitive reactive oxygen in-
termediates generated by CYP1A1 itself may induce further
expression of CYP1A1 through a mechanism that inactivates
NF-Y and related complexes. Further experiments are required
to test this hypothesis.
A major implication of our studies relates to the regulation of
MHC class II gene expression. MHC class II gene transcription
requires several functional DNA elements (53), and activation
of class II gene transcription requires NF-Y binding to the
Y-box element and NF-Y-mediated recruitment of additional
transcription factors to class II gene initiation start sites (54).
YB-1, an additional Y-box-binding protein, has been shown to
repress interferon g activation of MHC class II gene transcrip-
tion (55), and recently, dbpA and dbpB (mYB-1), two additional
Y-box-binding proteins, were shown to inhibit MHC class II
gene transcription by preventing NF-Y binding to the Y-box
through direct association with NF-YA and NF-YB, respec-
tively (56). In another study, mYB-1 has been shown to bind to
the Y-box and activate the MHC class II gene in response to
reactive oxygen intermediates such as hydrogen peroxide and
hydroxyl radicals (57). These studies, together with our obser-
vations in this report, suggest that modulation of MHC class II
gene transcription is controlled, in part, by cellular oxidative
and reducing environments, which can directly influence the
Y-box DNA binding activities of NF-Y and YB-1.
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